Lubrizol Deal Has $200 Million Breakup Fee

Lubrizol it could have to pay a $200 million breakup fee if it walks away from its $9 billion deal to sell itself to Warren Buffett's Berkshire Hathaway.

The lubricant maker would have to pay the fee if it cancels the deal because it has received a superior bid, the company said on Tuesday in a filing with the Securities and Exchange Commission.

Other scenarios where Lubrizol would be on the hook for the fee include if its shareholders fail to approve the bid or if its board of directors withdraws or changes its recommendation of the acquisition.

Berkshire struck the deal to buy Lubrizol for $135 a share in cash on Monday in a bet on industrial growth in emerging economies, SCANA Corp, Joe Lieberman, Democratic Senator Jeff Bingaman, Three Mile Island, Japan nuclear crisis, Japan earthquake, Japan tsunami,

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.